Welcome to our dedicated page for Pacer CSOP FTSE China A50 ETF news (Ticker: AFTY), a resource for investors and traders seeking the latest updates and insights on Pacer CSOP FTSE China A50 ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Pacer CSOP FTSE China A50 ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Pacer CSOP FTSE China A50 ETF's position in the market.
Pacer Advisors, Inc. has announced the closure and liquidation of two ETFs: the Pacer BioThreat Strategy ETF (VIRS) and the Pacer CSOP FTSE China A50 ETF (AFTY). Key points include:
1. Liquidation process begins on September 27, 2024
2. Funds will stop accepting new creation unit orders after close of business on October 10, 2024
3. Trading halts prior to market open on October 11, 2024 (Liquidation Date)
4. Cash distributions to remaining shareholders on or about the Liquidation Date
5. Distributions are taxable events
6. Fund termination follows completion of distributions
Shareholders are advised to consider tax implications and consult their advisors. The liquidation reflects careful consideration by the Board of Trustees of Pacer Funds Trust.